LDS/Medical Tests/Sporothrix Antibody, Serum

Sporothrix Antibody, Serum

Sporothrix is a dimorphic fungus that grows as a mold in the environment at 25 °C and converts to yeast form in human tissues at 37 °C. The primary pathogenic species, Sporothrix schenckii, causes sporotrichosis, a subacute or chronic fungal infection.

Most cases (~95%) present as lymphocutaneous sporotrichosis, where the fungus spreads from the inoculation site through local lymphatics, typically affecting the extremities and sometimes the face. Disseminated sporotrichosis occurs mainly in immunocompromised individuals (e.g., HIV/AIDS) and may involve bones, joints, lungs, or the central nervous system. Inhalation of fungal conidia, though uncommon, can result in pulmonary sporotrichosis, which is often severe and potentially fatal.

The infection induces a robust humoral and cellular immune response. Antigens from S. schenckii stimulate production of specific IgG, IgM, and IgA antibodies. In parallel, fungal cell wall ligands trigger Th1/Th17-mediated immunity, with increased release of cytokines such as IFN-γ, TNF-α, and IL-17A, promoting macrophage-mediated clearance.

Serological detection of Sporothrix antibodies supports the diagnosis of sporotrichosis, particularly in disseminated or extracutaneous disease. In cases of suspected sporotrichotic meningitis, comparison of cerebrospinal fluid (CSF) and serum antibody titers can aid in diagnosis. Antibody levels typically decline with effective treatment, making them useful for disease monitoring in selected cases.

  • Aids in the diagnosis of sporotrichosis, particularly disseminated or CNS involvement
  • May help monitor treatment response, as antibody titers decline with therapy

Positive result: Suggests current or past infection with Sporothrix. Correlation with clinical findings, culture, or histopathology is essential.

Negative result: Suggests absence of infection. However, false negatives may occur in early infection or during prolonged antifungal therapy.

Negative

Enzyme-linked immunosorbent assay (ELISA).

Serum, SST.

Stability

  • Ambient: 3-5 days
  • Refrigerated: 7-14 days
  • Frozen: 30 days
Fungal culture, CSF analysis, CBC, ESR, comprehensive metabolic panel.
1 to 3 days.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login